Onderzoeker
Lien De Beck
- Trefwoorden:Geneeskunde
- Disciplines:Toegepaste immunologie, Epigenetica, Celdood, Kankertherapie
Affiliaties
- Laboratorium voor Moleculaire en Cellulaire Therapie (Onderzoeksgroep)
Lid
Vanaf19 mrt 2021 → Heden - Basis (bio)-medische wetenschappen (Departement)
Lid
Vanaf1 okt 2018 → 30 sep 2023 - Basis (bio)-medische wetenschappen (Departement)
Lid
Vanaf1 okt 2017 → 20 okt 2022 - Faculteit van de Geneeskunde en Farmacie (Faculteit)
Lid
Vanaf23 aug 2017 → 23 mrt 2023 - Faculteit van de Geneeskunde en Farmacie (Faculteit)
Lid
Vanaf25 aug 2015 → 28 jun 2017
Projecten
1 - 1 of 1
- Moduleren van epigenetische mechanismen ter verbetering van kanker immuuntherapie.Vanaf1 okt 2018 → 30 sep 2022Financiering: FWO mandaten
Publicaties
1 - 7 van 7
- Application of epigenetic-targeting agents to confer immune modulation in cancer(2023)
Auteurs: L De Beck, K Breckpot, Karin Vanderkerken, Ken Maes
Aantal pagina's: 247 - Targeted radionuclide therapy with low and high-dose Lutetium-177 labeled single domain antibodies induces distinct immune signatures in a mouse melanoma model(2022)
Auteurs: T Ertveldt, L De Beck, Kirsten De Ridder, Hanne Locy, Wout De Mey, Cleo Goyvaerts, Q Lecocq, Hannelore Ceuppens, Y De Vlaeminck, R M Awad, et al.
Pagina's: 1136-1148 - Inhibiting Histone and DNA Methylation Improves Cancer Vaccination in an Experimental Model of Melanoma(2022)
Auteurs: L De Beck, R M Awad, Veronica Basso, Noelia Casares, Kirsten De Ridder, Y De Vlaeminck, Alessandra Gnata, Cleo Goyvaerts, Q Lecocq, Edurne San José-Enériz, et al.
Pagina's: 1-15 - TNF-alpha-Secreting Lung Tumor-Infiltrated Monocytes Play a Pivotal Role During Anti-PD-L1 Immunotherapy(2022)
Auteurs: Kirsten De Ridder, Hanne Locy, Elisa Piccioni, Miren Ibarra Zuazo, R M Awad, Stefaan Verhulst, Mathias Van Bulck, Y De Vlaeminck, Q Lecocq, Eva Reijmen, et al.
Pagina's: 1-15 - Evaluation of single domain antibodies as nuclear tracers for imaging of the immune checkpoint receptor human lymphocyte activation gene-3 in cancer(2021)
Auteurs: Q Lecocq, P Debie, Janik Puttemans, R M Awad, L De Beck, T Ertveldt, Y De Vlaeminck, Cleo Goyvaerts, G Raes, M Keyaerts, et al.
- Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade(2021)
Auteurs: R M Awad, Q Lecocq, Katty Zeven, T Ertveldt, L De Beck, Hannelore Ceuppens, Katrijn Broos, Y De Vlaeminck, Cleo Goyvaerts, Magali Verdonck, et al.
Pagina's: 172-182 - Epigenetic treatment of multiple myeloma mediates tumor intrinsic and extrinsic immunomodulatory effects(2018)
Auteurs: L De Beck, Sarah Melhaoui, Kim De Veirman, Eline Menu, Elke De Bruyne, Karin Vanderkerken, K Breckpot, Ken Maes